Search results
Johnson & Johnson to acquire Proteologix for $850 million
Reuters via Yahoo Finance· 5 hours agoProteologix's antibody PX128 is ready to enter early-stage development for moderate to severe atopic...
Johnson & Johnson Strikes $850 Million Deal to Boost Dermatology Portfolio
Market Watch· 5 hours agoJohnson & Johnson has agreed to buy privately-held biotechnology company Proteologix for an initial $850 million in cash in a deal that bolsters the healthcare ...
Johnson & Johnson (NYSE:JNJ) Shares Sold by Johnson Investment Counsel Inc.
ETF DAILY NEWS· 1 day agoJohnson Investment Counsel Inc. cut its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 12.4% in the 4th quarter, ...
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 2 days agoRecently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it...
Matt Gaetz invokes Trump’s infamous call to Proud Boys at trial: ‘Stand back and stand by’
The Independent via Yahoo News· 39 minutes agoSeveral Trump surrogates have shown up in court in recent days in what appears to be a bid to...
Catalyst Financial Partners LLC Trims Stock Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 4 days agoCatalyst Financial Partners LLC reduced its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 11.6% in the 4th quarter, according to its ...
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
The Motley Fool via AOL· 4 days agoMany healthcare investors look at Johnson & Johnson (NYSE: JNJ) and see a good, safe dividend stock....
NBC Securities Inc. Trims Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 1 day agoNBC Securities Inc. lessened its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 6.8% during the fourth quarter, according to its most recent ...
J&J hooks Proteologix for $850M cash, reeling in a roster of early bispecifics
FierceBiotech· 3 hours agoJohnson & Johnson is shelling out $850 million to buy Proteologix, getting hold of a young roster of...
Johnson & Johnson is selling its remaining Kenvue shares
Morningstar· 3 days agoJohnson & Johnson is selling its remaining shares in Kenvue Inc., the consumer-health business that it spun out last year. The company will exchange the ...